Fig. 1
From: A review of brain imaging biomarker genomics in Alzheimer’s disease: implementation and perspectives
Landscape of advances of the AD imaging biomarker genomics field. This field covers genomics, imaging, and clinical information, ultimately pointing towards integrated diagnosis and precision medicine. CSF cerebrospinal fluid, CT computed tomography, MMSE mini-mental state examination, MoCA montreal cognitive assessment, AVLT auditory-verbal learning test, AFT animal fluency test, BNT boston naming test, MES memory and executive screening scale